Company: ANY
Filing Date: 2025-12-22
Form Type: 8-K
Source: 0001062993-25-017451
Chunk: 2

Company: Sphere 3D Corp.
Filing Date: 2025-12-22
Form: 8-K
Item: Item 5.02
Chunk 2
---
Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 17, 2025 the Company appointed Ms. Reppas as its Chief Accounting Officer. Ms. Reppas will serve as the Company's principal financial and accounting officer. Ms. Reppas is an active Certified Public Accountant. Ms. Reppas has served as the Company's Vice President of Accounting and Finance since April 2025 and as the Company's Vice President of Finance and Corporate Controller from November 2017 to January 2019 and Corporate Controller from December 2014 to January 2019. Since July 2021 Ms. Reppas has been a fractional Chief Accounting Officer, Controller and advisor to small public and private companies. In this capacity she has been responsible for accounting and technical accounting functions, SEC compliance, managed audit, tax and banking audits, reviews and compliance, and supported capital raises and mergers and acquisition activities. From January 2019 to July 2021, Ms. Reppas served as Corporate Controller of Ra Medical Systems, Inc. (NYSE:RMED), Chief Accounting Officer and Corporate Controller from January 2020 to July 2021 and Vice President, Chief Accounting Officer and Corporate Controller from March 2021 to July 2021. Ms. Reppas is a former auditor with Deloitte & Touche LLP and holds a Bachelor of Arts, business economics with accounting emphasis, from the University of California at Santa Barbara.

There are no arrangements or understandings between Ms. Reppas and any other persons pursuant to which she was appointed as Chief Accounting Officer. There are no family relationships between Ms. Reppas and any director or executive officer of the Company and she has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K promulgated by the Securities and Exchange Commission.

Item 9.01. Financial Statements and Exhibits